Joseph L. Hooley's most recent trade in Idexx Laboratories, Inc. was a trade of 364 Non-Qualified Stock Option (right-to-buy) done . Disclosure was reported to the exchange on Sept. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| IDEXX Laboratories | Joseph L. Hooley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2025 | 364 | 364 | - | - | Non-Qualified Stock Option (right-to-buy) | |
| IDEXX Laboratories | Joseph L. Hooley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2025 | 158 | 158 | - | - | Restricted Stock Unit | |
| Aptiv | Joseph L. Hooley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2025 | 6,097 | 22,009 (0%) | 0% | 0 | Ordinary Shares | |
| Aptiv | Joseph L. Hooley | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.28 per share. | 22 Apr 2025 | 195 | 15,912 (0%) | 0% | 52.3 | 10,195 | Ordinary Shares |
| Exxon Mobil | Joseph Hooley L. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 2,500 | 20,500 (0%) | 0% | 0 | Common Stock |